Seeking Alpha

Novartis' (NVS +0.3%) RLX030 drug cut the number of deaths in patients with acute heart failure...

Novartis' (NVS +0.3%) RLX030 drug cut the number of deaths in patients with acute heart failure in a Phase III trial. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|